Management of Osteoarthritis
Start all patients with exercise and weight loss (if overweight), add topical NSAIDs for knee OA, then progress to oral NSAIDs if needed, reserving intra-articular corticosteroids for flares and refractory symptoms. 1
Core Foundation for All Patients
Exercise Programs (Strongly Recommended)
- Implement supervised exercise as the cornerstone of treatment for hand, hip, and knee OA, including walking, strengthening exercises, neuromuscular training, and aquatic exercise with no hierarchy among these options. 2, 1
- Supervised exercise programs produce superior outcomes compared to unsupervised programs. 2
- Exercise should be continued long-term as benefits diminish when discontinued. 1
Weight Management (Strongly Recommended)
- Prescribe weight loss for all overweight or obese patients with knee and/or hip OA to reduce joint loading and improve symptoms. 2, 1
- Even 5-10% body weight reduction produces clinically meaningful symptom improvement. 1
Self-Management Education (Strongly Recommended)
- Provide structured self-efficacy and self-management programs to all patients covering disease understanding, coping strategies, and activity pacing. 2, 1
Joint-Specific Physical Interventions
Hand OA
- Apply rigid or neoprene first carpometacarpal (CMC) joint orthoses for first CMC joint OA (strongly recommended). 2, 1
- Consider orthoses for other hand joints beyond the first CMC (conditionally recommended). 2, 1
Knee OA
- Use tibiofemoral bracing for tibiofemoral OA (strongly recommended). 2, 1
- Apply patellofemoral bracing for isolated patellofemoral OA (conditionally recommended). 2, 1
Hip OA
Pharmacological Treatment Algorithm
First-Line: Topical Therapy
- Apply topical NSAIDs for knee OA as first-line pharmacological treatment due to effective pain relief with minimal systemic exposure (strongly recommended). 1, 4
- Topical NSAIDs provide superior safety profile compared to oral formulations while maintaining efficacy. 1
Second-Line: Oral NSAIDs
- Prescribe oral NSAIDs for hand, knee, and hip OA when topical therapy is insufficient or impractical (strongly recommended). 2, 1, 5
- Use the lowest effective dose for the shortest duration to minimize gastrointestinal bleeding, cardiovascular events, and renal toxicity. 2, 1
- Assess cardiovascular disease, heart failure, gastrointestinal bleeding risk, hypertension, and chronic kidney disease before prescribing. 2
- Add proton pump inhibitor gastroprotection for patients at high gastrointestinal risk. 1
- Naproxen causes statistically significantly less gastric bleeding than aspirin at therapeutic doses. 5
Third-Line: Alternative Oral Agents
- Consider duloxetine for patients with inadequate response to NSAIDs or those with comorbid depression (conditionally recommended). 1, 4
- Consider acetaminophen for mild-to-moderate pain when NSAIDs are contraindicated, though recent evidence shows limited efficacy (conditionally recommended). 1, 4
- Reserve tramadol for refractory cases after other options have failed, recognizing dependence risks and side effects (conditionally recommended). 1, 4
Intra-Articular Injections
- Administer corticosteroid injections for knee and hip OA during acute flares or for short-term pain relief when oral medications are insufficient (strongly recommended). 1, 4
- Corticosteroid injections provide rapid symptom relief with relatively minor adverse effects. 4
Additional Therapeutic Modalities (Conditionally Recommended)
Physical Modalities
- Apply local heat or cold for symptomatic relief. 1
- Consider transcutaneous electrical nerve stimulation (TENS) for pain management. 1
- Use manipulation and stretching particularly for hip OA. 1
Mind-Body Interventions
- Incorporate yoga, cognitive behavioral therapy, or balance exercises for patients interested in integrative approaches. 1, 3
- These interventions may address comorbid mood disorders, sleep disturbances, and chronic pain that commonly accompany OA. 2
Treatments NOT Recommended
- Avoid glucosamine and chondroitin despite popular use, as evidence does not support efficacy. 1
- Do not use electroacupuncture based on current evidence. 1
- Avoid combining NSAIDs with aspirin as aspirin increases naproxen excretion and the combination increases adverse event frequency without demonstrated superior efficacy. 5
Critical Implementation Considerations
Comorbidity Assessment
- Screen for hypertension, cardiovascular disease, heart failure, gastrointestinal bleeding risk, and chronic kidney disease before finalizing pharmacological treatment plans. 2
- Evaluate disease severity, surgical history, and access to services (transportation, cost, insurance) when selecting physical therapy approaches. 2
Treatment Sequencing
- Begin with treatments having least systemic exposure or toxicity when choosing among pharmacological options. 2
- Use single interventions for mild disease, but employ multiple interventions in sequence or combination for moderate-to-severe symptoms. 2
Common Pitfalls
- Underutilization of exercise and weight management remains a major gap in OA care despite strong evidence. 6
- Overuse of opioid analgesics should be avoided; tramadol is only conditionally recommended for refractory cases. 6, 1
- Prolonged NSAID use without gastroprotection in high-risk patients increases serious gastrointestinal complications. 1